Tag: Nasdaq:KLRA

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist…

06/06/2026

- Advertisement -

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.

Subscribe to our newsletter to get our newest articles instantly!

I have read and agree to the terms & conditions

Leave this field empty if you’re human:

Subscribe to our newsletter and never miss our latest news, podcasts etc..

I have read and agree to the terms & conditions

Leave this field empty if you're human:

Zero spam, Unsubscribe at any time.

Welcome Back!

Sign in to your account

Username or Email Address

Password

Remember me